跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Humalog Mix50 Kwikpen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Humalog Mix50 Kwikpen
Approved
STANDARD
Humalog Mix50 Kwikpen
Eli Lilly Italia S.p.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cd51f8b3e420ac93
Company
Eli Lilly Italia S.p.A.
Type
Standard
Approval Details
Approval Id
cd51f8b3e420ac93
Drug Approval Philippines Name
Humalog Mix50 Kwikpen
Product Name
Humalog Mix50 Kwikpen
Registration Number
BR-990
Brand Name
Humalog Mix50 Kwikpen
Generic Name
Insulin Lispro
Dosage Form
Suspension for Injection (SC)
Dosage Strength
100 Units/mL (3.5 mg/mL) Suspension for Injection (SC) (50% Insulin Lispro and 50% Insulin Lispro Protamine)
Manufacturer
Eli Lilly Italia S.p.A.
Importer
Zuellig Pharma Corporation
Distributor
Zuellig Pharma Corporation
Issuance Date
28 October 2022
Expiry Date
28 October 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cd51f8b3e420ac93
Type
Standard
Back to Philippines FDA Approvals